Dominican Republic vs Mozambique: Deaths from Parkinson's disease
Dominican Republic
346.01 deaths
in 2021
Mozambique
336.48 deaths
in 2021
Dominican Republic rank
79th
Mozambique rank
80th
Deaths from Parkinson's disease over time
- Dominican Republic
- Mozambique
How they compare
Dominican Republic currently reports 346.01 deaths against 336.48 deaths in Mozambique, a difference of 9.53 deaths.
The two have swapped places 2 times across 22 shared years of data; in 2000 it was Dominican Republic ahead.
Dominican Republic ranks 79th and Mozambique ranks 80th of 194 countries.
Across the 3 decades both report, Dominican Republic averaged higher in 2 and Mozambique in 1.
Head to head by decade
| Decade | Dominican Republic | Mozambique | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 201.4 deaths | 180.92 deaths | 20.48 deaths | Dominican Republic |
| 2010s | 278.89 deaths | 304.59 deaths | 25.7 deaths | Mozambique |
| 2020s | 358.07 deaths | 354.16 deaths | 3.92 deaths | Dominican Republic |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher deaths from parkinson's disease, Dominican Republic or Mozambique?
- Dominican Republic, at 346.01 deaths against 336.48 deaths in Mozambique as of 2021.
- What is the difference in deaths from parkinson's disease between Dominican Republic and Mozambique?
- 9.53 deaths, with Dominican Republic ahead.
- How many years of comparable data are there for Dominican Republic and Mozambique?
- 22 years are reported by both, from 2000 to 2021.
- How do Dominican Republic and Mozambique rank globally for deaths from parkinson's disease?
- Dominican Republic ranks 79th and Mozambique ranks 80th of 194 countries.
- Where does this data come from?
- World Health Organization (2024) β with major processing by Our World in Data, published as Deaths from Parkinson's disease. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Estimated number of deaths from parkinson disease in both sexes.